Icopan 40mg Capsule contains Pantoprazole, a proton pump inhibitor (PPI) that effectively reduces gastric acid secretion by selectively inhibiting the H+/K+ ATPase enzyme system located in the gastric parietal cells. It is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and other conditions associated with excessive stomach acid production. Pantoprazole is also used for the prevention and treatment of gastric ulcers, including those induced by nonsteroidal anti-inflammatory drugs (NSAIDs). The 40mg dosage provides a potent and sustained acid suppression, promoting mucosal healing and symptom relief. Icopan is administered orally, with absorption unaffected by food intake, allowing flexible dosing schedules. The medication is generally well-tolerated, with adverse effects such as headache, diarrhea, nausea, and abdominal discomfort being infrequent and mild. Long-term use should be monitored due to potential risks including vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Icopan 40mg Capsule should be used under medical supervision, with dosage adjustments based on clinical response and patient-specific factors. It is contraindicated in patients with hypersensitivity to pantoprazole or other PPIs.